Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
Liang-Jie TangDan-Qin SunSherlot Juan SongTerry Cheuk-Fung YipGrace Lai-Hung WongPei-Wu ZhuSui-Dan ChenMorten Asser KarsdalDiana Julie LeemingPei JiangCong WangQiang ChenChristopher D ByrneGiovanni TargherMohammed EslamJacob GeorgeVincent Wai-Sun WongMing-Hua ZhengPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
The PERIOD score is helpful for accurately predicting the risk of MAFLD-CKD. PRO-C3 can also be used to assess liver fibrosis in people with MAFLD-CKD.